These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12198151)

  • 1. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.
    Chen SS; Chang PC; Cheng YW; Tang FM; Lin YS
    EMBO J; 2002 Sep; 21(17):4491-9. PubMed ID: 12198151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.
    Du J; Hannon GJ
    Nucleic Acids Res; 2002 Dec; 30(24):5465-75. PubMed ID: 12490715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
    Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S
    Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
    Katayama H; Sasai K; Kawai H; Yuan ZM; Bondaruk J; Suzuki F; Fujii S; Arlinghaus RB; Czerniak BA; Sen S
    Nat Genet; 2004 Jan; 36(1):55-62. PubMed ID: 14702041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
    Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
    J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.
    Stenoien DL; Sen S; Mancini MA; Brinkley BR
    Cell Motil Cytoskeleton; 2003 Jun; 55(2):134-46. PubMed ID: 12740874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
    Shinmura K; Bennett RA; Tarapore P; Fukasawa K
    Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.
    Meraldi P; Honda R; Nigg EA
    EMBO J; 2002 Feb; 21(4):483-92. PubMed ID: 11847097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
    Dumaz N; Meek DW
    EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
    Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
    Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.
    Miyoshi Y; Iwao K; Egawa C; Noguchi S
    Int J Cancer; 2001 May; 92(3):370-3. PubMed ID: 11291073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
    Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
    J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The over-expression of serine/threonine kinase 15 protein in oral carcinogenesis].
    Lu H; Cai Y; Yu YN; Yang H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Feb; 27(1):88-91. PubMed ID: 19323405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.
    Ewart-Toland A; Briassouli P; de Koning JP; Mao JH; Yuan J; Chan F; MacCarthy-Morrogh L; Ponder BA; Nagase H; Burn J; Ball S; Almeida M; Linardopoulos S; Balmain A
    Nat Genet; 2003 Aug; 34(4):403-12. PubMed ID: 12881723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic role of nuclear accumulated Aurora-A.
    Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
    Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase.
    Sun C; Newbatt Y; Douglas L; Workman P; Aherne W; Linardopoulos S
    J Biomol Screen; 2004 Aug; 9(5):391-7. PubMed ID: 15296638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal centrosome amplification and Aurora-A activation in p53-deficient cells.
    Oda-Sato E; Tanaka N
    J Nippon Med Sch; 2007 Dec; 74(6):384-5. PubMed ID: 18084130
    [No Abstract]   [Full Text] [Related]  

  • 20. Survivin inhibits anti-growth effect of p53 activated by aurora B.
    Jung JE; Kim TK; Lee JS; Oh SY; Kwak S; Jin X; Sohn JY; Song MK; Sohn YW; Lee SY; Pian X; Lee JB; Chung YG; Choi YK; You S; Kim H
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1164-71. PubMed ID: 16171786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.